Home » Films from the conference: Keynote speech, Policy Panel Speakers Q&A, and parallel panels

Films from the conference: Keynote speech, Policy Panel Speakers Q&A, and parallel panels

Keynote Speaker:


1.   Do you think there should be universal regulation for stem cell therapy provision that every country should follow?

2.   Should every country adopt the same regulations?

3.   The freedom of choice to medical treatment is often seen as an important aim by patient groups.  Is this freedom currently curtailed?

4.   What kinds of space should there be for innovative stem cell therapies?

In respose:

Insoo Hyun, Case Western Reserve University School of Medicine, USA


Policy Panellists, listed alphabetically (same questions to all):


1.   What kinds of stem cell therapy do you find unacceptable?

2.   What kind of space do researchers need to develop innovative therapies?

3.   What would you say to patients who say they cannot wait 5 or 10 years for certain stem cell therapies to be formally approved?

In response:

Paulo Bianco, University of Roma ‘La Sapienza’, Italy

Willem Fibbe, Leiden University Medical Centre, Netherlands

Hongyun Huang, Centre of Neurorestoratology, Beijing Rehabilitation Hospital of Capital Medical University, China

Kamthorn Pruksananonda, Chulalongkorn University, Bangkok Thailand

Alok Sharma, NeuroGen Brain and Spine Institute, Mumbai India

Geeta Shroff, Nutech Mediworld, New Dehli India


Parallel panel session films:

Resistance and alter-standardisation in emerging medicine research:  The role of global asymmetries

‘Medical wellness tourism’:  Bionetworking across boundaries

How ethics and religion shape stem cell research

International life science platforms and bionetworking — Putting back the people in the platform

Cord Blood Banking and Bionetworking:  Different stakes in different countries